Greenwich LifeSciences (GLSI) Intangibles (2019 - 2025)
Greenwich LifeSciences (GLSI) posted Intangibles of $876.0 for Q1 2025, down 50.76% on a QoQ basis from $1779.0 in Q4 2024, and down 80.48% year-over-year from $4488.0 in Q1 2024.
Greenwich LifeSciences (GLSI) Intangibles (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' Intangibles history runs 7 years deep, the most recent figure standing at $876.0 for Q1 2025.
- Quarterly Intangibles fell 80.48% year-over-year to $876.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $876.0 (down 80.48% YoY) and the FY2024 annual result came in at $1779.0, down 67.0% from the prior year.
- Intangibles was $876.0 for Q1 2025 at Greenwich LifeSciences, down from $1779.0 in the prior quarter.
- Across five years, Intangibles topped out at $15324.0 in Q1 2021 and bottomed at $876.0 in Q1 2025.
- A 5-year average of $8100.0 and a median of $8100.0 in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2021 — Intangibles decreased 21.09% — and 2025, when it tumbled 80.48%.
- Greenwich LifeSciences' Intangibles stood at $12615.0 in 2021, then slipped by 28.63% to $9003.0 in 2022, then sank by 40.12% to $5391.0 in 2023, then plunged by 67.0% to $1779.0 in 2024, then tumbled by 50.76% to $876.0 in 2025.
- Business Quant data shows GLSI's Intangibles at $876.0 in Q1 2025, $1779.0 in Q4 2024, and $2682.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 876.00 |
| Dec 31, 2024 | 1,779.00 |
| Sep 30, 2024 | 2,682.00 |
| Jun 30, 2024 | 3,585.00 |
| Mar 31, 2024 | 4,488.00 |
| Dec 31, 2023 | 5,391.00 |
| Sep 30, 2023 | 6,294.00 |
| Jun 30, 2023 | 7,197.00 |
| Mar 31, 2023 | 8,100.00 |
| Dec 31, 2022 | 9,003.00 |
| Sep 30, 2022 | 9,906.00 |
| Jun 30, 2022 | 10,809.00 |
| Mar 31, 2022 | 11,712.00 |
| Dec 31, 2021 | 12,615.00 |
| Sep 30, 2021 | 13,518.00 |
| Jun 30, 2021 | 14,421.00 |
| Mar 31, 2021 | 15,324.00 |
| Dec 31, 2020 | 16,227.00 |
| Sep 30, 2020 | 17,130.00 |
| Dec 31, 2019 | 19,836.00 |